| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/06/2000 | US6071914 Comparing the prolactin profile of a mammal to a standard prolactin profile for healthy mammals of the same species and sex and adjusting the prolactin profile of the afflicted mammal to conform to the standard; circadian rhythm rhythms |
| 06/06/2000 | US6071912 Inhibit human factor xa and are therefore useful as pharmacological agents for the treatment of disease-states characterized by thrombotic activity; amino-, oxy- and thia-substituted triazines |
| 06/06/2000 | US6071911 4-amino-1-arylpyridin-2-ones and process for making |
| 06/06/2000 | US6071910 Use of agents to treat eosinophil-associated pathologies |
| 06/06/2000 | US6071909 Phenylbenzimidazole derivatives as ligands for GABA receptors |
| 06/06/2000 | US6071908 Radiation-activated cytotoxin therapy of neoplastic disease |
| 06/06/2000 | US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases |
| 06/06/2000 | US6071905 Treating tuberculosis, mycobacteriosis, viral and immune diseases, chlamydia infections, antitumor and -carcinogenic agents; microbiocides, in particular to mycobacteria resistant to isoniazide; stimulantes interferons |
| 06/06/2000 | US6071904 Process for manufacturing ophthalmic suspensions |
| 06/06/2000 | US6071902 Administering olanzapine or a salt or solvate to a mammal where the mammal is not clinically diagnosed with a psychotic condition; abnormalities in 5-ht; patients and prisoners in institutions; suicides |
| 06/06/2000 | US6071901 Treating pain, hyperalgesia and/or inflammatory conditions in which c-fibers play a pathophysiological role; inhibition of neurogenic inflammation involving the release of neuro-peptide from peripheral and central endings of sensory nerves |
| 06/06/2000 | US6071900 Heterocyclic compounds and their use |
| 06/06/2000 | US6071899 Azetidinone derivatives for the treatment of atherosclerosis |
| 06/06/2000 | US6071898 Asiatic acid derivatives having modified A-ring |
| 06/06/2000 | US6071897 Use of vitamin D compounds to prevent transplant rejection |
| 06/06/2000 | US6071896 Suppression of thromboxane levels by percutaneous administration of aspirin |
| 06/06/2000 | US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein |
| 06/06/2000 | US6071888 Comprising a ribose compound, l-beta-alanine, ascorbic acid, and nicotinic acid; useful for treating melanoma |
| 06/06/2000 | US6071886 β,β-distributed derivatives of 9-deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A |
| 06/06/2000 | US6071885 Administering a cardiac glycosides and aglycone derivatives to inhibit export of leaderless proteins into extracellular spaces; useful in treatment of tumors and diabetes |
| 06/06/2000 | US6071884 Administering to the patient atleast one alpha-galactosylceramide to treat thrombocytopenia |
| 06/06/2000 | US6071883 Administering flavone derivative as an immunosuppressant to the recipient in need of a graft rejection prevention or suppression after allograft organ transplant |
| 06/06/2000 | US6071882 Administering an effective synergistic amount of leuteinizing hormone releasing hormone antagonist cetrorelix in combination with alpha-receptor blocking agents to treat the prostate hypertrophy and prostate cancer |
| 06/06/2000 | US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents |
| 06/06/2000 | US6071694 Screening method for therapeutic agents against Alzheimer's disease |
| 06/06/2000 | US6071543 Applying metal salt topically to skin |
| 06/06/2000 | US6071538 Oral delivery composition comprising supramolecular complex |
| 06/06/2000 | US6071537 Administering cyclohexylmethanesulfamic acid or pyranyl-2-methanesulfamic acid derivatives |
| 06/06/2000 | US6071533 Mixing with hydrophilic polymer to increase shelf life |
| 06/06/2000 | US6071531 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 06/06/2000 | US6071530 Dispensing solution of biodegradable, water insoluble, thermoplastic resin with biocompatible solvent onto support; coagulation |
| 06/06/2000 | US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery |
| 06/06/2000 | US6071521 Pharmaceutical composition having an antitumor activity and a process for preparation thereof |
| 06/06/2000 | US6071514 Administering activated protein c and antiplatelet agent and/or anticoagulant |
| 06/06/2000 | US6071509 Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor |
| 06/06/2000 | US6071497 Microparticles for lung delivery comprising diketopiperazine |
| 06/06/2000 | US6071494 Lipid, protein or polymer and a gas or gaseous precursor, in combination with a renal vasodilator. |
| 06/06/2000 | CA2207018C Diltiazem hydrochloride formulation |
| 06/06/2000 | CA2206233C Combination dosage form comprising cetirizine and pseudoephedrine |
| 06/06/2000 | CA2198599C Salts of an anti-migraine indole derivative |
| 06/06/2000 | CA2163073C New solar filters, photoprotective cosmetic compositions incorporating same and uses thereof |
| 06/06/2000 | CA2145541C Cosmetic composition containing retinol |
| 06/06/2000 | CA2114830C Lactone compound and process of production thereof |
| 06/06/2000 | CA2101466C Taste-masking composition of bitter pharmaceutical agents |
| 06/06/2000 | CA2058975C Antiinflammatory gel preparation |
| 06/06/2000 | CA2032900C The diastereoselective preparation of phosphinate esters |
| 06/06/2000 | CA2029651C Tricyclic pteridinones and a process for their preparation |
| 06/06/2000 | CA2015033C Tertiary alkyl functionalized piperazine derivatives |
| 06/06/2000 | CA2002649C Cardioprotective tocopherol analogs |
| 06/04/2000 | CA2291471A1 Lowering blood levels of lipoprotein(a) |
| 06/03/2000 | CA2290847A1 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol |
| 06/02/2000 | WO2000031548A1 Prevention and treatment of amyloid-associated disorders |
| 06/02/2000 | WO2000031532A1 Methods of identifying viral therapeutics |
| 06/02/2000 | WO2000031273A2 Process for oxidising terpenes |
| 06/02/2000 | WO2000031247A2 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 06/02/2000 | WO2000031235A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 06/02/2000 | WO2000031133A2 Potassium channel interactors and uses therefor |
| 06/02/2000 | WO2000031127A2 Protein fragments for use in protein targeting |
| 06/02/2000 | WO2000031120A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 06/02/2000 | WO2000031112A1 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 06/02/2000 | WO2000031109A1 USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION |
| 06/02/2000 | WO2000031100A2 Benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031098A1 Injectable anthelmintic formulation |
| 06/02/2000 | WO2000031097A1 13-membered azalides and their use as antibiotic agents |
| 06/02/2000 | WO2000031096A1 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031095A2 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031094A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031093A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031092A2 Benzyllactobionamides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | WO2000031085A1 Organophosphorous compounds and the use thereof |
| 06/02/2000 | WO2000031084A1 Prostaglandin conjugates for treating or preventing bone disease |
| 06/02/2000 | WO2000031077A1 Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid |
| 06/02/2000 | WO2000031076A1 Crystal modification b of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1,4- dihydro-4- oxo-3-quinoline carboxylic acid |
| 06/02/2000 | WO2000031075A1 Crystal modification a of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro- 4-oxo-3- quinoline carboxylic acid |
| 06/02/2000 | WO2000031074A2 Indole derivatives and their use as serotonin receptor ligands |
| 06/02/2000 | WO2000031073A1 Benzoxazole derivatives and drugs containing the same as the active ingredient |
| 06/02/2000 | WO2000031070A1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 06/02/2000 | WO2000031068A1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 06/02/2000 | WO2000031067A1 Propanoic acid derivatives as integrin inhibitors |
| 06/02/2000 | WO2000031065A1 Compounds having cytokine inhibitory activity |
| 06/02/2000 | WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 06/02/2000 | WO2000031062A1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 06/02/2000 | WO2000031060A1 Scavenger compounds |
| 06/02/2000 | WO2000031059A1 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses |
| 06/02/2000 | WO2000031058A1 Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine |
| 06/02/2000 | WO2000031055A1 Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione |
| 06/02/2000 | WO2000031054A1 Il-5 inhibiting 6-azauracil derivatives |
| 06/02/2000 | WO2000031053A1 Il-5 inhibiting 6-azauracil derivatives |
| 06/02/2000 | WO2000031051A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors |
| 06/02/2000 | WO2000031050A1 Quinoline and quinoxaline compounds |
| 06/02/2000 | WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors |
| 06/02/2000 | WO2000031048A1 N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases |
| 06/02/2000 | WO2000031047A1 Substituted 4-amino-2-aryl-cyclopenta[d]pyrimidines, their production and use and pharmaceuticalreparations containing same |
| 06/02/2000 | WO2000031046A1 Novel acylguanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them |
| 06/02/2000 | WO2000031044A1 Iminoguanidine derivatives, preparation method, use as medicines |
| 06/02/2000 | WO2000031039A1 Substituted benzo[de]isoquinoline-1,3-diones |
| 06/02/2000 | WO2000031038A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 06/02/2000 | WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 06/02/2000 | WO2000031036A1 Novel naphthalene derivatives |
| 06/02/2000 | WO2000031035A1 New manufacturing process |